Fulminant Devic disease successfully treated by lymphocytapheresis [2]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 9, 2006, Pages 1094-1095

  Nozaki, Ichiro ^a   Hamaguchi, T ^a   Komai, K ^a   Yamada, M ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; CYTOKINE;

ADULT; CASE REPORT; CLINICAL FEATURE; CYTAPHERESIS; FEMALE; HUMAN; LABORATORY TEST; LETTER; LYMPHOCYTE; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; DRUG RESISTANCE; IMMUNOLOGY; LEUKAPHERESIS;

ADULT; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKAPHERESIS; METHYLPREDNISOLONE; NEUROMYELITIS OPTICA;

EID: 33747379819     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.086306     Document Type: Letter

References (5)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromylitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12.
2. Aguilera AJ, Carlow TJ, Smith KJ, et al. Lymphocytaplasmapheresis in Devic's syndrome. Transfusion 1985;25:54-6.
3. Kleinman S, Nichols M, Strauss F, et al. Use of lymphoplasmapheresis or plasmapheresis in the management of acute renal allograft rejection. J Clin Apheresis 1982;1:14-7.
4. Ochi H, Wu XM, Osoegawa M, et al. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperlgEaemic myelitis. J Neuroimmunol 2001;119:297-305.
5. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004;63:2363-70.